Finally, ROR1, a tyrosine kinase-like orphan receptor highly expressed in MCL, binds to CD19 and this complex can activate PI3K/AKT as well as MEK/ERK1/2 pathways [79]. This evidence concerns the gene AKT1 and mantle cell lymphoma.